In August, Trump said he wouldn't rule out taking away access to mifepristone, which was also mentioned by the policy ...

FDA Chief Robert Califf reflects on potential changes as Trump's re-election looms, expressing disappointment and ...

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...

J&J filed a lawsuit Tuesday in the US District Court for the District of Columbia alleging the US Health Resources and ...

Responding to Law Enforcement and Safeguarding Your Interests - In this final installment of our series on government ...

A new study found that many people on Medicare with low to moderate incomes don't have enough money to pay for a hospital ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular", the "Company"), a biopharmaceutical company committed to improving vision in the real world through ...

"I am thrilled to further strengthen and enrich Ocular's senior leadership team with the appointment of Namrata as Chief ...

The Biosecurity Act, which prohibits US pharma companies from doing business with certain countries ... our supply chain will remain top priorities. FDA clearance for Goa was a major step and we plan ...

Harriett said he is telling clients who want to buy a particular drug plan that doesn’t pay him commission that ... them CMS canceled their certification – they can’t write business, they can’t be ...

In 2025, if the plan has a deductible, the $35 will not count towards that amount, but it will count towards the $2,000 ...